Eisbach Bio GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://www.eisbach.bio
EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid TumorHRR DeficiencyHomologous Recombination Deficiency
- Interventions
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Eisbach Bio GmbH
- Target Recruit Count
- 144
- Registration Number
- NCT06525298
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath